Skip to main content
    Find Your Path

    What's Changing for Medicare in 2027

    Every confirmed 2027 change in one place — Part D costs, the premium subsidy ending, negotiated drug prices — plus what CMS has not announced yet.

    Published August 19, 2026 · Updated November 10, 2026

    Advertisement
    Comparison table of 2026 versus 2027 Medicare figures: Part D deductible $615 to $700 and out-of-pocket cap $2,100 to $2,400 (final), Part B premium $202.90 to $209.50 and Part B deductible $283 to $292 (projected). Sources: CMS; 2026 Medicare Trustees Report

    The short version

    • Confirmed: Part D deductible $700, out-of-pocket cap $2,400, base beneficiary premium $41.33.
    • Confirmed: the federal subsidy holding down standalone drug plan premiums ends December 31, 2026.
    • Confirmed: 15 more drugs get Medicare-negotiated prices starting January 1, 2027.
    • Confirmed: Social Security benefits rise 3.6% in January 2027.
    • CMS estimate: the average Medicare Advantage premium falls to $12.00 a month in 2027, and the average stand-alone drug plan premium rises to $36. Your plan's premium can differ.
    • Not yet announced: Part B premium, Part B deductible, Part A costs, IRMAA brackets. CMS usually publishes these in November.
    • Open Enrollment runs October 15 to December 7, 2026. Changes you make start January 1.

    Medicare's 2027 changes arrived in two waves, which is why coverage of them has been confusing. A batch of prescription drug figures was finalized back in April. Then in late July, CMS announced something nobody had on the calendar: a program that has been quietly holding down drug plan premiums since 2025 is being retired.

    The rest — your Part B premium, your deductible, the IRMAA income brackets — won't be announced until roughly November. This page tracks all of it, and gets updated as each piece lands.

    What's confirmed right now

    Locked in for 2027
    20262027
    Part D deductible (standard)$615$700
    Part D out-of-pocket cap$2,100$2,400
    Part D base beneficiary premium$38.99$41.33
    Insulin cap (month's supply)$35$35
    Recommended adult vaccines$0$0
    Social Security COLA2.8%3.6%
    Average Medicare Advantage premium (projected)$14.37$12.00
    Average stand-alone drug plan premium (projected)$35.09$36
    Highest Medicare Advantage in-network out-of-pocket limit$9,250$9,850
    High-deductible Medigap Plan F, G or J deductible$2,950$3,050
    Telehealth from home under Original MedicareCoveredCovered through Dec 31, 2027
    Advertisement

    The three changes that matter most

    1. Part D costs more before the cap kicks in

    The deductible rose 13.8% and the cap rose 14.3% — both far steeper than last year's increases. If you take ongoing brand-name or specialty medication, you'll reach $0 cost sharing later in the year than you did in 2026.

    Read the full 2027 Part D breakdown

    2. The premium stabilization subsidy ends

    On July 28, 2026, CMS announced it is ending the Part D Premium Stabilization Demonstration after this year. The program reduced the base premium and capped how much any plan could raise premiums year over year. Without it, standalone drug plan premiums return to open-market pricing. In its September 28, 2026 announcement, CMS projected that the average standalone drug plan premium would rise by less than $1 a month, from $35.09 in 2026 to $36 in 2027. KFF's October 2 analysis found modest premium increases for many enrollees, but said some face much larger increases if they do not switch plans, including $50 or more a month in United's AARP Medicare Rx Preferred plan.

    People on Original Medicare with a standalone drug plan are most exposed. Medicare Advantage enrollees are largely insulated, and Extra Help recipients are unaffected.

    What the subsidy ending means for your premium

    3. Fifteen more drugs get negotiated prices

    The second round of Medicare drug price negotiation takes effect January 1, 2027, with discounts from 38% to 85%. Semaglutide — Ozempic, Rybelsus, and Wegovy — drops to $274 for a 30-day supply from a $959 list price. The negotiated price applies where Part D already covers the drug, such as Ozempic for diabetes. It doesn't add weight-loss coverage: Part D still excludes drugs used for weight loss, and that coverage runs through the separate GLP-1 Bridge until the end of 2027.

    See all 15 negotiated drug prices for 2027

    Also for 2027: the sales and payment rules changed

    CMS finalized the Contract Year 2027 Medicare Advantage and Part D rule on April 2, 2026, removing the 48-hour wait between signing a Scope of Appointment and a plan-specific sales call, restructuring Star Ratings, and tightening supplemental benefit card rules. Separately, the finalized MA payment increase came in at 2.48% — about $13 billion — after an initial proposal of 0.09%.

    Why your 2027 Medicare sales call could come faster

    If your plan is being discontinued for 2027

    Members whose Medicare Advantage or Part D plan is not renewing receive a Notice of Termination by October 2 instead of an Annual Notice of Change. That letter starts a Special Enrollment Period running December 8 through February 28 — and a separate Medigap guaranteed-issue window that closes around March 4.

    What happens if your 2027 Medicare plan is cancelled

    Why benefits may still shrink after a payment increase

    CMS finalized a 2.48% Medicare Advantage payment increase for 2027, but brokers reviewing preliminary plan filings report another year of broad benefit reductions. The early signals include dental cuts, higher specialist copays, drug cost-sharing changes, and smaller Part B premium givebacks.

    Why 2027 Medicare Advantage benefits are still shrinking

    More 2027 coverage

    What hasn't been announced yet

    Still pending — expect around November 2026
    Figure2026 (confirmed)2027 status
    Part B premium$202.90Projected ~$209.50
    Part B deductible$283.00Projected ~$292
    Part A hospital deductible$1,736Not announced
    IRMAA income bracketsStart above $109,000 single / $218,000 jointNot announced

    Treat the Part B projection as a planning floor, not a forecast. The 2026 Trustees Report puts it at $209.50, but the prior year's report projected $218.60 for the same year before revising down $9. Several private forecasters currently expect $216–$219. Build in a buffer.

    Advertisement

    Your 2027 calendar

    Dates that matter
    DateWhat happens
    Sept 30, 2026 (done)Annual Notice of Change letters arrived
    Oct 1, 2026 (done)2027 plans went live in Medicare Plan Finder
    Oct 14, 2026 (done)3.6% COLA announced
    Oct 15 – Dec 7, 2026Open Enrollment: change or keep your plan
    ~Nov 2026CMS confirms Part B, Part A, and IRMAA figures
    Jan 1, 2027Everything above takes effect
    Jan 1 – Mar 31Medicare Advantage Open Enrollment

    The bottom line

    The prescription drug side of 2027 is settled and mostly points one direction: you'll pay somewhat more before your protections kick in, and standalone drug plan premiums are the wild card. The medical side — Part B, Part A, IRMAA — is genuinely unknown until November, and anyone quoting you a firm number today is quoting a projection. The one thing worth doing before December 7: compare your plan against the alternatives in Plan Finder instead of letting it renew by default.

    Sources